World / Science & Health | FOCUS Mar 25, 2022
Drugmakers and scientists begin the hunt for long COVID treatments
by Jennifer Rigby and Julie Steenhuysen
Leading drugmakers, including those who have launched pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease.
